Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Synthomer plc (SYNT.L)
London, GB
Synthomer plc functions as a leading producer of specialty chemicals, with its operations organized into four primary divisions: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company develops and supplies an extensive array of chemical products serving various industries. Its offerings include a wide selection of adhesives, such as pressure-sensitive variants, acrylic polymers, dispersions, saturants, and release coatings. For the construction sector, Synthomer provides critical materials like water-based carboxylated styrene butadiene rubber, redispersible powders, and specialized flooring adhesives. In the textile industry, it manufactures impregnation binders, styrene butadiene copolymers, and other polymer binders. Synthomer's product range also features binders specifically designed for carpets, alongside synthetic binders, additives, and plastic pigments essential for diverse paper coating applications, including graphic, packaging, and specialty papers. The company formulates various binders, dispersions, and both water-based and solvent-borne resins tailored for a broad spectrum of coating requirements. Its advanced materials extend to components for foamed bedding and footwear, elastomeric modifiers used in thermoplastics, and reinforcement resins vital for rubber compounds, notably latex for tire cords. Furthermore, Synthomer supplies compounds and aqueous curing pastes for applications such as carpets, in addition to acrylic monomers crafted to enhance the performance characteristics of polymer formulations, and antioxidant products. A key area of its specialization involves latices for different types of gloves, encompassing those used in medical examinations, clean rooms, food handling, and industrial settings, prominently including high-performance nitrile latex. The company also offers a suite of industrial chemicals suchides, polyvinyl alcohol, polyvinyl acetates, thermosetting resins, and other inorganic materials, alongside coalescing agents that improve the properties of coatings. Established in 1863, Synthomer plc maintains its headquarters in London, United Kingdom. The company underwent a name change in 2012, having formerly operated under the name Yule Catto & Co. plc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.60% | +17.33% | +115.38% | +313.54% | +86.86% | +59.41% | -9.10% | -87.65% | -97.24% | -95.71% | -81.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 7 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.5% Q4'25: -9.1% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-118.2% Q4'25: +5.4% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.1% Q4'25: +9.5% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%-0.4% Q4'25: -6.2% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%-0.4% Q4'25: -13.0% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q4'25: +119.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.97× Q4'25: 2.75× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
527.95M
est: 558.27M (-5.4%)
|
569.52M
est: 640.54M (-11.1%)
|
1.06B
est: 1.17B (-9.1%)
|
1.05B
est: 1.16B (-9.6%)
|
992.70M
est: 1.09B (-8.7%)
|
936.40M
est: 982.96M (-4.7%)
|
870.10M
est: 900.37M (-3.4%)
|
1.05B
est: 1.06B (-0.9%)
|
1.48B
est: 1.43B (+3.2%)
|
1.62B
est: 1.52B (+6.7%)
|
1.46B
est: 1.50B (-2.6%)
|
1.64B
est: 1.72B (-4.1%)
|
2.14B
est: 2.30B (-6.9%)
|
2.33B
est: 2.60B (-10.3%)
|
1.97B
est: 1.97B (-0.2%)
|
1.99B
est: 1.96B (+1.1%)
|
1.74B
est: 1.78B (-2.2%)
|
1.86B
1.84B – 1.89B
+4.5% YoY
|
1.93B
1.80B – 2.09B
+3.9% YoY
|
2.04B
1.95B – 2.14B
+5.4% YoY
|
| EBITDA |
66.54M
est: 61.83M (+7.6%)
|
71.18M
est: 15.49M (+359.6%)
|
90.16M
est: 107.32M (-16.0%)
|
111.30M
est: 24.69M (+350.9%)
|
113.80M
est: 86.99M (+30.8%)
|
107.80M
est: 83.92M (+28.5%)
|
116.60M
est: 86.81M (+34.3%)
|
195.80M
est: 133.65M (+46.5%)
|
159.30M
est: 233.88M (-31.9%)
|
180.10M
est: 162.50M (+10.8%)
|
168.20M
est: 161.26M (+4.3%)
|
254.50M
est: 160.44M (+58.6%)
|
394.40M
est: 183.45M (+115.0%)
|
139.40M
est: 188.90M (-26.2%)
|
113.40M
est: 166.59M (-31.9%)
|
83.00M
est: 167.41M (-50.4%)
|
137.00M
est: 150.07M (-8.7%)
|
156.82M
154.83M – 159.41M
+4.5% YoY
|
163.00M
151.58M – 176.41M
+3.9% YoY
|
171.80M
164.63M – 180.35M
+5.4% YoY
|
| EBIT |
17.44M
est: 46.21M (-62.3%)
|
62.49M
est: 19.51M (+220.4%)
|
48.22M
est: 119.51M (-59.7%)
|
76.10M
est: 54.27M (+40.2%)
|
94.80M
est: 70.37M (+34.7%)
|
86.60M
est: 67.75M (+27.8%)
|
94.80M
est: 60.51M (+56.7%)
|
145.40M
est: 95.74M (+51.9%)
|
96.40M
est: 188.85M (-49.0%)
|
128.40M
est: 103.97M (+23.5%)
|
111.00M
est: 124.35M (-10.7%)
|
153.80M
est: 123.05M (+25.0%)
|
299.10M
est: 140.70M (+112.6%)
|
10.30M
est: 144.88M (-92.9%)
|
-39.90M
est: 44.75M (-189.2%)
|
-13.40M
est: 44.97M (-129.8%)
|
-6.30M
est: 40.31M (-115.6%)
|
42.12M
41.59M – 42.82M
+4.5% YoY
|
43.78M
40.72M – 47.39M
+3.9% YoY
|
46.15M
44.22M – 48.44M
+5.4% YoY
|
| Net Income |
9.69M
est: 51.26M (-81.1%)
|
49.74M
est: 11.13M (+346.9%)
|
-6.95M
est: 90.40M (-107.7%)
|
56.60M
est: -6.90M (+920.8%)
|
48.30M
est: 53.17M (-9.2%)
|
45.30M
est: 43.63M (+3.8%)
|
60.40M
est: 42.11M (+43.4%)
|
110.40M
est: 72.01M (+53.3%)
|
74.00M
est: 144.09M (-48.6%)
|
99.80M
est: 80.65M (+23.7%)
|
84.60M
est: 96.43M (-12.3%)
|
3.10M
est: 94.13M (-96.7%)
|
208.70M
est: 107.62M (+93.9%)
|
-32.50M
est: -158.60M (+79.5%)
|
-67.00M
est: -83.30M (+19.6%)
|
-72.60M
est: -7.78M (-833.0%)
|
-157.00M
est: -20.39M (-669.9%)
|
-639.6K
-731.1K – -548.2K
+96.9% YoY
|
6.70M
-5.72M – 19.12M
+1,147.2% YoY
|
14.98M
14.10M – 15.87M
+123.7% YoY
|
| SGA |
42.03M
est: 68.19M (-38.4%)
|
44.43M
est: 87.89M (-49.4%)
|
75.14M
est: 148.25M (-49.3%)
|
97.20M
est: 112.83M (-13.9%)
|
54.30M
est: 96.11M (-43.5%)
|
51.30M
est: 49.05M (+4.6%)
|
72.10M
est: 47.68M (+51.2%)
|
94.50M
est: 85.96M (+9.9%)
|
109.60M
est: 123.34M (-11.1%)
|
113.20M
est: 119.45M (-5.2%)
|
96.80M
est: 109.37M (-11.5%)
|
179.20M
est: 107.70M (+66.4%)
|
169.60M
est: 123.15M (+37.7%)
|
161.50M
est: 126.81M (+27.4%)
|
166.60M
est: 131.49M (+26.7%)
|
198.80M
est: 132.14M (+50.4%)
|
—
est: 118.45M (-100.0%)
|
123.78M
122.21M – 125.82M
+4.5% YoY
|
128.66M
119.65M – 139.25M
+3.9% YoY
|
135.60M
129.95M – 142.36M
+5.4% YoY
|
| EPS |
0.03
est: 0.13 (-80.1%)
|
0.21
est: 0.15 (+41.1%)
|
-0.05
est: 0.19 (-128.5%)
|
0.44
est: 0.20 (+121.2%)
|
2.84
est: 0.19 (+1,397.7%)
|
2.67
est: 0.18 (+1,405.2%)
|
3.56
est: 1.48 (+140.4%)
|
6.50
est: 1.82 (+257.0%)
|
4.35
est: 2.05 (+111.9%)
|
5.84
est: 2.18 (+168.2%)
|
1.58
est: 1.94 (-18.4%)
|
0.05
est: 2.12 (-97.5%)
|
3.56
est: 5.20 (-31.5%)
|
-0.51
est: 1.74 (-129.3%)
|
-0.78
est: -0.54 (-45.5%)
|
-0.44
est: -0.05 (-829.4%)
|
-0.96
est: -0.12 (-733.9%)
|
0.00
0.00 – 0.00
+96.6% YoY
|
0.06
-0.03 – 0.12
+1,699.8% YoY
|
0.09
0.09 – 0.10
+45.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.01% | 1.15M | 0.36% |
| 2 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 13.1K | 0.30% |
| 3 | State Street SPDR FTSE UK All Share UCITS ETF (Acc) FTAL.L | 0.00% | 28.5K | 0.20% |
| 4 | State Street SPDR FTSE UK All Share UCITS ETF (Dist) FTAD.L | 0.00% | 28.5K | 0.20% |
| 5 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.00% | 16.8K | 0.39% |
| 6 | Avantis International Equity ETF AVDE | 0.00% | 131.2K | 0.23% |
| 7 | Dimensional - International Small Cap ETF DFIS | 0.00% | 33.4K | 0.39% |
| 8 | Avantis Responsible International Equity ETF AVSD | 0.00% | 2.0K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael Willome | Chief Executive Officer & Executive Director | 1M | male |
| Lily Liu | Chief Financial Officer & Director | 1M | female |
| Faisal Tabbah | Vice President of Investor Relations | — | male |
| Jan Chalmovsky | President of Strategy and M&A | — | male |
| Rob Tupker | President of Health, Protection, Performance Materials & Asia | — | male |
| Ana Perroni Laloe | President of Coatings & Construction Solutions and EMEA | — | female |
| Stephan Lynen | President of Adhesive Solutions | — | male |
| Anant Prakash | Interim Chief Human Resources Officer, Chief Counsel & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SYNT.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
